Corrigendum to “Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests” [J Microbiol Immunol Infect (2015) 924–933](S1684118215008191)(10.1016/j.jmii.2015.06.009)

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has a mistake. The updated affiliation for Shio-Shin Jeana,* in the author affiliations should be corrected to “aDepartment of Emergency Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; bDepartment of Emergency and Critical Care Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; cDepartment of Emergency, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”

Original languageEnglish
Pages (from-to)157
Number of pages1
JournalJournal of Microbiology, Immunology and Infection
Volume51
Issue number1
DOIs
Publication statusPublished - 2016

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Corrigendum to “Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests” [J Microbiol Immunol Infect (2015) 924–933](S1684118215008191)(10.1016/j.jmii.2015.06.009)'. Together they form a unique fingerprint.

Cite this